Cardiol Therapeutics On Track To Provide New Standard Of Care For Cardiovascular Diseases ($CRDL)
While Cardiol Therapeutics stock may have given back some of its gains to profit-taking, investors holding since the new year have little to complain about. After all, since the turn to 2023, CRDL...
Nuevo Leóx United States Cienciae Humanismo University Of Ottawa Heart Institute Houston Methodist Debakey Heart Vascular Center Mcgill University Health Centre
Source: marketscreener.com